6533b7ddfe1ef96bd127541d
RESEARCH PRODUCT
Valvular Heart Disease
Massimo MidiriF. CoppolinoMassimo GaliaEmanuele GrassedonioGiuseppe La TonaGiuseppe Lo ReLudovico La GruttaGiovanni Gentilesubject
Aortic valvemedicine.medical_specialtyMitral regurgitationmedicine.diagnostic_testbusiness.industryvalvular heart diseaseMagnetic resonance imaging030204 cardiovascular system & hematologymedicine.disease3. Good health030218 nuclear medicine & medical imagingCoronary artery disease03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureMitral valveValvular Heart DiseaseAngiographyCardiac valvemedicineRadiologybusinessSettore MED/36 - Diagnostica Per Immagini E Radioterapiadescription
Valvular heart disease (VHD) refers to a wide spectrum of cardiac disorders that affect a large number of patients. Echocardiography is still considered the pivotal imaging method to evaluate the cardiac valves. However, echocardiography has some intrinsic limitations due to operator dependence and patient habitus. In the last two decades three-dimensional techniques such as magnetic resonance imaging (MRI) and computed tomography (CT) have provided valuable assessment of VHD. MRI overcomes the limitation of the poor acoustic window of echocardiography without ionizing radiation. Nowadays, MRI aims to be considered as the reference standard for imaging cardiac valves because of the improved morphological visualization and reproducible assessment of ventricular volume, mass, and function. CT can display the morphologic features of valves and allow their functional assessment in the setting of congenital and acquired disorders. Moreover, CT angiography may be performed to rule out coronary artery disease in presurgical planning and to follow up patients with prosthetic valves.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2013-01-01 |